News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
437,134 Results
Type
Article (18713)
Company Profile (54)
Press Release (418356)
Multimedia
Podcasts (107)
Webinars (21)
Section
Business (143529)
Career Advice (1436)
Deals (23797)
Drug Delivery (98)
Drug Development (47187)
Employer Resources (145)
FDA (9679)
Job Trends (9455)
News (208949)
Policy (19040)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (3)
Academia (1273)
Accelerated approval (39)
ADA (24)
Adcomms (16)
Allergies (133)
Alliances (32436)
ALS (155)
Alzheimer's disease (1138)
Antibody-drug conjugate (ADC) (436)
Approvals (10153)
Artificial intelligence (611)
ASCO (221)
Autoimmune disease (304)
Automation (52)
Bankruptcy (192)
Best Places to Work (7669)
BIO (66)
BIOSECURE Act (19)
Biosimilars (163)
BioSpace Insights (135)
Biotechnology (50)
Bladder cancer (168)
Brain cancer (55)
Breast cancer (510)
Cancer (4636)
Cardiovascular disease (325)
Career advice (1251)
Career pathing (45)
CAR-T (281)
CDC (35)
Celiac Disease (2)
Cell therapy (763)
Cervical cancer (43)
Clinical research (43728)
Collaboration (1687)
Commercialization (6)
Company closure (3)
Compensation (487)
Complete response letters (62)
COVID-19 (1334)
CRISPR (74)
C-suite (1056)
Cystic fibrosis (101)
Data (6727)
Decentralized trials (2)
Denatured (40)
Depression (128)
Dermatology (70)
Diabetes (365)
Diagnostics (4615)
Digital health (44)
Diversity (8)
Diversity, equity & inclusion (33)
Drug discovery (291)
Drug pricing (164)
Drug shortages (30)
Duchenne muscular dystrophy (207)
Earnings (50025)
Editorial (63)
Employer branding (17)
Employer resources (126)
Events (62514)
Executive appointments (973)
FDA (12851)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (19)
Frontotemporal dementia (26)
Funding (1328)
Gene editing (168)
Generative AI (57)
Gene therapy (548)
GLP-1 (610)
Government (2660)
Grass and pollen (3)
Guidances (363)
Healthcare (10796)
Hematology (132)
HIV (68)
Huntington's disease (37)
IgA nephropathy (91)
Immunology and inflammation (151)
Immuno-oncology (81)
Indications (171)
Infectious disease (1576)
Inflammatory bowel disease (153)
Inflation Reduction Act (13)
Influenza (90)
Intellectual property (264)
Interviews (226)
IPO (10766)
IRA (49)
Job creations (2026)
Job search strategy (1045)
JPM (48)
Kidney cancer (20)
Labor market (97)
Layoffs (208)
Leadership (42)
Legal (3876)
Licensing (5)
Liver cancer (74)
Longevity (20)
Lung cancer (612)
Lymphoma (388)
Machine learning (56)
Management (47)
Manufacturing (960)
Marketing (11)
MASH (161)
Medical affairs (1)
Medical device (8653)
Medtech (8810)
Mergers & acquisitions (14279)
Metabolic disorders (984)
mRNA (128)
Multiple sclerosis (148)
NASH (12)
Neurodegenerative disease (287)
Neuropsychiatric disorders (70)
Neuroscience (2279)
NextGen: Class of 2026 (3869)
Non-profit (1891)
Now hiring (29)
Obesity (431)
Opinion (303)
Ovarian cancer (197)
Pain (177)
Pancreatic cancer (283)
Parkinson's disease (266)
Partnered (28)
Patents (526)
Patient recruitment (623)
Peanut (37)
People (42590)
Pharmaceutical (17)
Pharmacy benefit managers (30)
Phase 1 (13844)
Phase 2 (19332)
Phase 3 (14568)
Pipeline (8585)
Policy (283)
Postmarket research (1113)
Preclinical (5289)
Press Release (56)
Prostate cancer (239)
Psychedelics (40)
Radiopharmaceuticals (282)
Rare diseases (832)
Real estate (3764)
Recruiting (65)
Regulatory (16770)
Reports (49)
Research institute (1275)
Resumes & cover letters (224)
Rett syndrome (41)
RNA editing (16)
RSV (54)
Schizophrenia (140)
Series A (241)
Series B (164)
Service/supplier (3)
Sickle cell disease (76)
Special edition (23)
Spinal muscular atrophy (81)
Sponsored (37)
Startups (2236)
State (1)
Stomach cancer (12)
Supply chain (109)
Tariffs (87)
The Weekly (64)
Vaccines (569)
Venture capital (94)
Weight loss (251)
Women's health (86)
Worklife (20)
Date
Today (115)
Last 7 days (564)
Last 30 days (1748)
Last 365 days (21205)
2026 (13377)
2025 (20916)
2024 (24186)
2023 (27295)
2022 (35743)
2021 (37560)
2020 (35829)
2019 (29555)
2018 (21949)
2017 (20579)
2016 (18728)
2015 (21949)
2014 (15924)
2013 (13034)
2012 (14265)
2011 (14846)
2010 (13171)
Location
Africa (527)
Alabama (60)
Alaska (4)
Arizona (198)
Arkansas (8)
Asia (36940)
Australia (6880)
California (9830)
Canada (2985)
China (1317)
Colorado (414)
Connecticut (512)
Delaware (237)
Europe (59625)
Florida (1527)
Georgia (248)
Hawaii (4)
Idaho (28)
Illinois (841)
India (106)
Indiana (401)
Iowa (19)
Japan (573)
Kansas (68)
Kentucky (29)
Louisiana (30)
Maine (63)
Maryland (1065)
Massachusetts (7106)
Michigan (286)
Minnesota (427)
Mississippi (4)
Missouri (115)
Montana (17)
Nebraska (22)
Nevada (131)
New Hampshire (71)
New Jersey (2935)
New Mexico (17)
New York (2815)
North Carolina (1236)
North Dakota (8)
Northern California (4982)
Ohio (316)
Oklahoma (18)
Oregon (18)
Pennsylvania (1938)
Puerto Rico (28)
Rhode Island (33)
South America (778)
South Carolina (77)
Southern California (3992)
Tennessee (151)
Texas (1519)
United States (35018)
Utah (282)
Vermont (2)
Virginia (268)
Washington D.C. (42)
Washington State (849)
West Virginia (4)
Wisconsin (114)
Wyoming (1)
437,134 Results for "ventracor limited formerly micromedical industries ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
L7 Informatics Makes the Case for an Agentic Operating System as the Strategic Foundation for Regulated Process Industries
L7 CEO Vasu Rangadass, Ph.D., argues that regulated process industries have reached the limits of point-solution modernization and must pivot to unified orchestration to unlock the promise of agentic AI.
June 15, 2026
·
1 min read
Press Releases
Allotera Therapeutics (Formerly Wugen) Closes $35 Million Financing to Advance Off-the-Shelf CAR-T Therapies for T-Cell Cancers
July 8, 2026
·
5 min read
Press Releases
Visionary Holdings’ Subsidiary Nanjing Tuoyuanjian Health Technology Co., Ltd. Enters into Distribution Agreement with Suncare (Shanghai) Health Technology Co., Ltd.
Collaboration Expected to Expand the Commercialization of Stem Cell Aesthetic and Anti-Aging Products Through an AI-Enabled Community Healthcare and Senior Care Network in China
July 29, 2026
·
4 min read
Press Releases
Mighty Therapeutics, Formerly Stealth BioTherapeutics, Announces New Name Honoring the Mitochondrial Disease Community
June 16, 2026
·
6 min read
Press Releases
Alpha Pro Tech, Ltd. Announces Second Quarter 2026 Financial Results
August 6, 2026
·
16 min read
Press Releases
Propanc Biopharma Signs MOU with Avance Clinical Pty Ltd
July 7, 2026
·
5 min read
Press Releases
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
July 16, 2026
·
6 min read
Press Releases
Medicus Pharma Appoints Dr. Faisal Mehmud as Chief Executive Officer of Antev Limited, United Kingdom
August 3, 2026
·
7 min read
Press Releases
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
February 25, 2026
·
5 min read
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunity Patrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
1 of 43,714
Next
